Abstract
BACKGROUND: Corona virus is continuing over a year ago throughout the world. To handle the spread and vitality of the virus, several investigations have been done and recently the vaccine has launched in order to effect soon. A vaccine has several controversial issues regarding the effectiveness and potential unwanted serious adverse effects. In low-and middle-income countries including Ethiopia, there is a huge knowledge gap and insufficiency of information about the corona vaccine. Trust is exceptionally crucial to utilize any vaccines apply on human being. This study aimed to assess trust about corona vaccine and its associated factors among health professionals working at Dilla University referral hospital, Southern Ethiopia, 2021. METHOD: A hospital-based study employing cross-sectional design and simple random sampling technique was used to select health professionals who are working at Dilla University referral hospital from March 1-15, 2021. Trust about corona vaccine was assessed by a Likert scale type single standard questionnaire. A Binary Logistic regression at 95% CI, p < 0.05 was used to identify factors associated with the outcome variable. RESULT: This study included 250 health professionals. From the total of respondents, 155(62%) indicated they would not trust COVID-19 vaccines. The most common reasons indicated through a closed series of 10 options for not trusting the vaccine included doubts in efficacy, novelty of the products, fast-tracking of the development and general indecisiveness. Men, people aged less than 32 years, who were single, who worked in a coronavirus treatment unit, who had a positive coronavirus test and no current history of physical illness were more likely to trust or demand the vaccine. CONCLUSIONS: The proportion of health professionals that trust COVID-19 vaccination is among the lowest in the world. Therefore, there is a need of awareness creation training and education about the corona vaccine for health professionals, particularly for those identified groups.